耳蜗前庭神经微血管减压术治疗耳鸣和眩晕:个体患者数据的系统评价与Meta分析
本研究遵循PRISMA-IPD指南,系统检索MEDLINE、EMBASE和Google Scholar(检索于2016年1月),纳入35项研究共572例患者,评估耳蜗前庭神经微血管减压术治疗耳鸣和/或眩晕的有效性、安全性及预后因素。结果显示耳鸣完全缓解率28%,眩晕32%,耳鸣合并眩晕62%,11%患者报告至少1项并发症;个体患者数据Meta分析(165例)显示合并症状者成功几率高于单纯耳鸣者(OR 3.8,95%CI 1.45-10.10)。作者认为因成功率低且并发症率较高,微血管减压术不能作为耳鸣或眩晕的标准治疗方法。
要点
- 耳鸣完全缓解率28%,眩晕32%,耳鸣合并眩晕62%。
- 11%患者报告至少1项并发症。
- 合并症状者成功几率高于单纯耳鸣者(OR 3.8,95%CI 1.45-10.10)。
核心结论
- 因成功率低,微血管减压术不能被视为耳鸣或眩晕的标准治疗方法。
- 此外发现相当的并发症率。
- 合并症状患者有更高成功机会,当合并症状出现时神经血管冲突更可能是潜在病理,微血管减压术可能合适。
- 由于纳入研究证据水平低,该结论须谨慎对待,需进一步验证以评估合并症状患者是否确实是微血管减压术的更佳候选者。
研究设计与样本
- 系统评价与个体患者数据Meta分析,遵循PRISMA-IPD指南。
- 通过MEDLINE、EMBASE和Google Scholar综合检索(检索于2016年1月)识别合格研究。
- 纳入35项研究共572例患者,所提供证据水平低。
- 个体患者数据Meta分析纳入165例患者,采用逻辑回归分析并考虑研究聚类。
主要发现
- 28%耳鸣患者和32%眩晕患者报告微血管减压术后完全缓解。
- 同时有耳鸣和眩晕的患者中62%完全缓解。
- 11%患者报告至少1项并发症。
- 个体患者数据Meta分析(165例)显示同时有耳鸣和眩晕的患者较单纯耳鸣患者有更高成功机会(OR 3.8,95%CI 1.45-10.10)。
- 无其他变量与成功显著相关。
关键数值与推荐
- 耳鸣完全缓解率28%。
- 眩晕完全缓解率32%。
- 耳鸣合并眩晕完全缓解率62%。
- 至少1项并发症报告率11%。
- 合并症状较单纯耳鸣的成功OR 3.8(95%CI 1.45-10.10)。
临床怎么用
- 作者认为因成功率低,微血管减压术不能作为耳鸣或眩晕的标准治疗方法。
- 作者认为当合并症状出现时,神经血管冲突更可能是潜在病理,微血管减压术可能合适。
- 作者指出由于纳入研究证据水平低,该结论须谨慎对待,需进一步验证以评估合并症状患者是否确实是微血管减压术的更佳候选者。
局限性
- 纳入研究所提供的证据水平低。
- 由于纳入研究证据水平低,结论须谨慎对待。
- 需进一步验证以评估合并症状患者是否确实是微血管减压术的更佳候选者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Microvascular decompression (MVD) is regarded as a valid treatment modality in neurovascular conflicts (NVCs) causing, for example, trigeminal neuralgia and hemifacial spasms. An NVC of the cochleovestibular nerve might cause tinnitus and/or vertigo; however, general acceptance of MVD for this indication is lacking. The aim of this study was to investigate the effectiveness, safety, and prognostic factors for success of MVD of the cochleovestibular nerve. METHODS A systematic review and meta-analysis of individual patient data (IPD) were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Individual Patient Data (PRISMA-IPD) guidelines. By a comprehensive search (conducted in January 2016) in MEDLINE, EMBASE, and Google Scholar, eligible studies were identified. The collected outcome was a global measurement of improvement of 1) tinnitus, 2) vertigo, and 3) tinnitus combined with vertigo. For the meta-analysis, IPD were collected from the papers and/or from the authors. IPD were analyzed with logistic regression analysis while accounting for study clustering. RESULTS Thirty-five studies (572 patients) were included. The level of evidence provided by these studies was low. In 28% of patients with tinnitus and 32% of patients with vertigo, complete relief following MVD was reported. Patients with both tinnitus and vertigo had complete relief in 62% of cases. In 11% of patients, ≥ 1 complications were reported. Meta-analysis of IPD (165 patients) demonstrated that patients with both tinnitus and vertigo had a higher chance of success (OR 3.8, 95% CI 1.45-10.10) than patients with tinnitus alone. No other variables were significantly related to success. CONCLUSIONS Due to low success rates, MVD cannot be considered as a standard treatment method for tinnitus or vertigo. Moreover, a substantial complication rate was found. However, patients with combined symptoms had a higher chance of success. When combined symptoms occur, it is more likely that an NVC is the underlying pathology and MVD might be appropriate. Due to the low level of evidence in the included studies, this conclusion must be taken with caution. Further validation is necessary to evaluate whether patients with combined symptoms are indeed better candidates for MVD.
引用
- van den Berge MJC, van Dijk JMC, Posthumus IA, et al. Microvascular decompression of the cochleovestibular nerve for treatment of tinnitus and vertigo: a systematic review and meta-analysis of individual patient data. J Neurosurg. 2016. PMID: 27911239. doi:10.3171/2016.8.JNS16992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。